Recently, it has been shown that hepatic steatosis following HFD results in the induction of liver PCSK9 mRNA and protein, a process involving saturated FA-induced, SREBP2-driven de novo PCSK9 expression (Lebeau et al., 2019b). Here, SREBF2 is linked to fatty liver disease.